SCHEMBL14153148

SCHEMBL14153148

CCC(OC)c1nc(-c2ccc(-c3ccncc3)cc2)no1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 10/20 0.57
NPC1 O15118 7/20 0.50
RAB9A P51151 6/20 0.50
MAPT P10636 5/20 0.50
SMN1; SMN2 Q16637 5/20 0.50
ALDH1A1 P00352 4/20 0.50
LMNA P02545 2/20 0.50
TP53 P04637 1/20 0.50
S1PR3 Q99500 4/20 0.48
NFKB1 P19838 2/20 0.47
NFKB2 Q00653 2/20 0.47
RELA Q04206 2/20 0.47
HSD17B10 Q99714 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 2/20 0.46
TSHR P16473 1/20 0.45
KDM4E B2RXH2 1/20 0.45
TTR P02766 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15913657 0.88 S1PR1 (0.48) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14153797 0.86 S1PR1 (0.43) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14153213 0.86 RAB9A (0.49) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14153100 0.82 S1PR1 (0.62) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14153246 0.81 S1PR1 (0.61) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14153146 0.81 S1PR1 (0.61) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14153212 0.80 TSHR (0.53) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14059920 0.80 NPC1 (0.41) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14153110 0.79 S1PR1 (0.40) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL19090054 0.79 S1PR1 (0.66) S1PR1NPC1RAB9AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012162635-A1 METABOTROPIC GLUTAMATE RECEPTORS 5 MODULATORS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2012-11-29 WO disclosed